Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure
A Bianco, M Canepa, GA Catapano, M Marvisi… - Journal of Clinical …, 2024 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is often part of a more complex
cardiopulmonary disease, especially in older patients. The differential diagnosis of the acute …
cardiopulmonary disease, especially in older patients. The differential diagnosis of the acute …
[HTML][HTML] Tools & Trackers
R Fogel - statnews.com
Why is it that we have not seen the urgency in COPD management we would expect for a
disease of this burden and scale? As a trained pulmonologist, and having dedicated my …
disease of this burden and scale? As a trained pulmonologist, and having dedicated my …
[HTML][HTML] AstraZeneca ADR New AstraZeneca Data Presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPD …
T Avanza - placera.se
Results from the EROS real-world retrospective study showed that initiating fixed-dose triple-
combination therapy BREZTRI AEROSPHERE®(budesonide/glycopyrronium/formoterol …
combination therapy BREZTRI AEROSPHERE®(budesonide/glycopyrronium/formoterol …
[HTML][HTML] Nuevos datos de AstraZeneca presentados en el Congreso ATS 2023 apoyan la intervención temprana con Trixeo para el tratamiento de la EPOC
ECV US - vademecum.es
★ Nuevos datos de AstraZeneca presentados en el Congreso ATS 2023 apoyan la
intervención temprana con Trixeo para el tratamiento de la EPOC ☰ Inicio Vademecum Box …
intervención temprana con Trixeo para el tratamiento de la EPOC ☰ Inicio Vademecum Box …
[HTML][HTML] New AstraZeneca data presented at ATS 2023 strengthen the body of evidence supporting early intervention with Breztri in COPD
ECV US - astrazeneca.com
Results from the EROS real-world retrospective study showed that initiating fixed-dose triple-
combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) …
combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) …
[引用][C] New AstraZeneca Data Presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPD
L y Mundo, NYN Jersey, D de Columbia, I Latente